Vaccine News and Research

Latest Vaccine News and Research

Yo-yo dieting and sugar-bingeing can lead to anxiety and withdrawal symptoms

In research that sheds light on the perils of yo-yo dieting and repeated bouts of sugar-bingeing, researchers from The Scripps Research Institute have shown in animal models that cycling between periods of eating sweet and regular-tasting food can activate the brain's stress system and generate overeating, anxiety, and withdrawal-like symptoms.

10 Nov 2009

H1N1 cases increase in China, Japan; Afghanistan attempts to contain virus

The WHO on Friday reported on a rising number of H1N1 (swine flu) cases in China and Japan, Reuters/Washington Post reports. "In China, after an earlier wave of mixed influenza activity (seasonal H3N2 and pandemic H1N1), pandemic H1N1 influenza activity now predominates and is increasing," the agency said. "Sharp increases in pandemic flu infections continue to be reported throughout Japan, particularly on the northern island," the news service writes (Nebehay, 11/6).

10 Nov 2009

VOA News examines conculsion of MIM Pan-African Malaria Conference

The 5th Multilateral Initiative on Malaria (MIM) Pan-African Conference ended Friday in Nairobi, Kenya, " with scientists expressing optimism about several developments in the works to prevent, treat, and possibly eradicate a disease that kills nearly one million people in Africa each year," VOA News reports.

10 Nov 2009

TRICARE South Region beneficiaries urged to get H1N1 influenza vaccinations

Humana Military Healthcare Services, a wholly-owned subsidiary of Humana Inc. (NYSE: HUM), encourages TRICARE South Region beneficiaries to get their H1N1 influenza vaccinations in an effort to reduce the spread of the virus. Anticipating a greater need for the shots, the Department of Defense (DoD) is encouraging all military personnel to obtain the vaccines.

9 Nov 2009

VaxInnate licensed to use 3M Drug Delivery Systems' TLR agonists

3M Drug Delivery Systems has signed an agreement with VaxInnate Corporation under which VaxInnate acquires the use of 3M’s patented toll-like receptor (TLR) agonists for use as vaccine adjuvants. Data suggest that 3M’s TLR agonists could enhance vaccine potency, potentially enabling VaxInnate to develop vaccines that provide faster, more robust protection.

9 Nov 2009

Positive study data from Zosano Pharma's ZP-PTH transdermal patch for treating osteoporosis

Zosano Pharma, Inc., a privately held pharmaceutical company developing products using a novel transdermal delivery technology, announced publication in the current issue of the Journal of Clinical Endocrinology and Metabolism of results from a positive phase 2 study of its rapid-delivery transdermal patch (ZP-PTH) for the treatment of postmenopausal osteoporosis.

9 Nov 2009

Caliper Life Sciences announces financial results for third quarter ended September 30, 2009

Caliper Life Sciences, Inc. today reported results for its third quarter ended September 30, 2009. GAAP revenues increased by 4% to $32.2 million, from non-GAAP revenues of $31.0 million in the same period of 2008, which represents GAAP revenue of $34.0 million in the third quarter of 2008 reduced by $3.0 million for the impact of divested product lines.

9 Nov 2009

Cellular mechanisms that may impact immune functions in the elderly discovered

Investigators discover cellular mechanisms that may impact the decline of both innate and adaptive immune functions that increase the susceptibility to various infectious agents, cancer and diseases in the elderly say experts at the annual meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Miami Beach, Fla.

9 Nov 2009

Poll examines the American public's response to H1N1 vaccine shortage

A new national poll from Harvard School of Public Health (HSPH) researchers found that a majority of adults who tried to get the H1N1 vaccine for themselves or their children have been unable to do so. The poll, which examines the American public's response to the H1N1 vaccine shortage, is the fifth in a series of surveys of public views concerning the H1N1 flu outbreak undertaken by the Harvard Opinion Research Program at HSPH.

7 Nov 2009

PPD acquires Excel PharmaStudies

PPD, Inc. today announced it has completed its acquisition of Excel PharmaStudies, Inc., the market leader and one of the largest contract research organizations in China. The acquisition strengthens PPD’s full range of drug development services in the country and positions it to capitalize on the tremendous growth of the outsourcing market in Asia Pacific.

7 Nov 2009

GeoVax Labs announces financial results and operational update for the third quarter of 2009

GeoVax Labs, Inc., an Atlanta-based, biopharmaceutical company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, today announced its third quarter 2009 financial results and provided an operational update.

6 Nov 2009

Swine flu vaccine distribution to New York companies causes uproar

The distribution of swine flu vaccines to big name companies in New York has caused an uproar as people complain that children and health care workers should receive top priority. The New York Times reports: "New York City health officials have distributed small amounts of the swine flu vaccine to some major New York companies, including Wall Street banks like Goldman Sachs and Citigroup, even as shortages continue.

6 Nov 2009

55% of adult population in Greater Washington, DC say they will not get H1N1 flu vaccine, reveals poll results

Fifty-five percent of the adult population in the Greater Washington, DC region say they will not get the H1N1 flu vaccine, according to a new poll commissioned by the Greater Washington Board of Trade.

6 Nov 2009

H1N1 is now most dominant flu strain worldwide, WHO says

The H1N1 (swine flu) virus is now the dominant flu strain worldwide, the WHO reported Thursday, with the virus accounting for up to 70 percent of the flu viruses sampled in some countries, the Associated Press reports.

6 Nov 2009

Bioniche Life Sciences announces financial results for its Fiscal 2010 first-quarter

Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, today announced financial results for its Fiscal 2010 first quarter, ended September 30, 2009.

6 Nov 2009

First Edition: October 6, 2009

Today's headlines highlight activity on different fronts -- with House Democrats scrambling to hold together fragile support for tomorrow's health bill vote while Republican lawmakers and other health reform opponents intensify their attack.

6 Nov 2009

UTSA releases its newest research numbers

The University of Texas at San Antonio (UTSA) released its newest research numbers today, reporting a 34% increase to $46,521,487 in total research spending for the Sept. 1, 2008 – Aug. 31, 2009 fiscal year (FY 09) over the previous fiscal year, when research spending totaled $34,601,444. The statistic is up 97% from just five years ago, when UTSA’s total research expenditures were $23,605,844.

6 Nov 2009

CREW urge HHS to investigate CDC's approval to distribute H1NI vaccine to Wall Street firms

Today, Citizens for Responsibility and Ethics in Washington (CREW) asked Health and Human Service (HHS) Secretary Kathleen Sebelius to investigate why the Center for Disease Control (CDC) approved the distribution of the H1NI vaccine to Wall Street firms at a time when the vaccine is unavailable to most Americans.

6 Nov 2009

Eggs sensitivity and flu shot: Doctors' dilemma

"My three year old had a skin breakout we think was due to eggs - is it safe to do a flu shot?" It's a question being asked to every doctor who takes care of kids during flu season. "On the one hand we are concerned about the devastating effects of the new strain of flu, and on the other we aren't sure if a history of eggs sensitivity is enough to hold the shot or spray," said Bobby Q. Lanier, M.D., clinical professor of pediatrics at the University of North Texas HSC in Fort Worth, Texas, and executive medical director of the American College of Allergy, Asthma and Immunology (ACAAI).

6 Nov 2009

Journal of Infectious Diseases' special edition on rotavirus

The Journal of Infectious Diseases has released a special edition, Global Rotavirus Surveillance: Preparing for the Introduction of Rotavirus Vaccines. This special edition provides a significant contribution to the understanding of rotavirus disease burden and the impact of rotavirus vaccines, which have the potential to save an estimated 228,000 lives annually.

6 Nov 2009

Vaccine News and Research

Latest Vaccine News and Research

Yo-yo dieting and sugar-bingeing can lead to anxiety and withdrawal symptoms

H1N1 cases increase in China, Japan; Afghanistan attempts to contain virus

VOA News examines conculsion of MIM Pan-African Malaria Conference

TRICARE South Region beneficiaries urged to get H1N1 influenza vaccinations

VaxInnate licensed to use 3M Drug Delivery Systems' TLR agonists

Positive study data from Zosano Pharma's ZP-PTH transdermal patch for treating osteoporosis

Caliper Life Sciences announces financial results for third quarter ended September 30, 2009

Cellular mechanisms that may impact immune functions in the elderly discovered

Poll examines the American public's response to H1N1 vaccine shortage

PPD acquires Excel PharmaStudies

GeoVax Labs announces financial results and operational update for the third quarter of 2009

Swine flu vaccine distribution to New York companies causes uproar

55% of adult population in Greater Washington, DC say they will not get H1N1 flu vaccine, reveals poll results

H1N1 is now most dominant flu strain worldwide, WHO says

Bioniche Life Sciences announces financial results for its Fiscal 2010 first-quarter

First Edition: October 6, 2009

UTSA releases its newest research numbers

CREW urge HHS to investigate CDC's approval to distribute H1NI vaccine to Wall Street firms

Eggs sensitivity and flu shot: Doctors' dilemma

Journal of Infectious Diseases' special edition on rotavirus

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in